World
On the surface, Sun Pharma’s $3.2-billion purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may...
Hi, what are you looking for?
On the surface, Sun Pharma’s $3.2-billion purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may...
Top Indian drug giant Sun Pharmaceutical Industries said Monday it had agreed to buy its troubled peer Ranbaxy for $4.0 billion in stock, ending...
Shares in Indian drug giant Ranbaxy fell as much as four percent on Monday following news of a second recall of its cholesterol-busting generic...
Generic drug makers Ranbaxy of India and Teva of Israel have agreed to settle allegations they made an illegal pact to restrict competition in...
Shares in one of India’s biggest drugmakers, Ranbaxy Laboratories, dropped 17 percent on Friday after the US Food and Drug Administration suspended imports from...